The Role and Therapeutic Potential of Host Defense Peptides — Peptide Design

The Role and Therapeutic Potential of Host Defense Peptides – Peptide Design

Hancock, R. E. W., & Sahl, H.-G. (2006). Cationic host defence peptides: novel antimicrobial strategies against old and new pathogens. Nature Reviews Drug Discovery, *5*(2), 123–130. https://doi.org/10.1038/nrd2201

Nature boasts over 2,000 antimicrobial peptides with more than 50 unique structural types, providing a powerful impetus for designing novel and enhanced antimicrobial peptides. To date, most peptide development has involved structure-assisted design, optimizing key characteristics through a moderate number of modifications to parent molecules. These characteristics typically include amphipathicity (the presence of polar and hydrophobic residues in separate regions of the final peptide structure), net charge, the flexibility and compatibility of hydrophobic residues, and specific secondary structures.

Many design principles, particularly for the α-helical structural class, are derived from studies on highly simplified peptides rich in lysine and leucine. These peptides consist of only 2–3 different amino acid types and are used to model specific structural features: helical hydrophobic moments, overall hydrophobicity, directional antimicrobial activity, etc. This approach has successfully yielded optimized antimicrobial peptides with enhanced activity, even against particularly resilient (multidrug-resistant) bacteria. However, it limits the diversity of candidate molecules screened.

For this reason, there is growing interest in developing screening methods that allow for random mutagenesis of antimicrobial peptides. To date, several promising strategies have emerged. Early on, Blondelle and Houghten constructed combinatorial peptide libraries using a mixed peptide deconvolution strategy. Unfortunately, this method is sometimes limited to small peptides—for instance, screening a hexamer library and identifying a 6-amino-acid peptide active against *Staphylococcus aureus*.

A second strategy involves recombinant processes, where random mutations are introduced at multiple positions in synthetic genes encoding the peptides to generate recombinant peptide libraries. However, screening these recombinant peptides remains challenging. A third, more recent strategy utilizes cellulose-supported machine-translation synthesis to generate diverse peptide libraries.